Quercetin: The Complete Evidence-Based Guide

Quercetin is a flavonoid — a plant polyphenol found in onions, apples, capers, berries, broccoli, and green tea. It is one of the most abundant dietary antioxidants in the human diet, with over 10,000 published papers on PubMed.

Quercetin operates on three mechanisms: senolysis (killing zombie cells by inhibiting Bcl-2/Bcl-xL), senomorphic suppression (reducing SASP inflammatory output via NF-kB inhibition), and Nrf2 activation (preventing new zombie cells by activating the body's antioxidant defence system).

Yes. Quercetin acts as a senolytic by inhibiting the Bcl-2 and Bcl-xL anti-apoptotic proteins that senescent cells upregulate to protect themselves, allowing the cell to be destroyed. It may also inhibit autophagic flux specifically in senescent cells, triggering apoptosis.

Senolytic action kills zombie cells, while senomorphic action reduces the inflammatory SASP output of zombie cells that haven't yet been cleared. Quercetin does both — the only natural compound to credibly do both simultaneously.

D+Q (dasatinib + quercetin) is a clinical senolytic combination used in Mayo Clinic trials. Dasatinib is a prescription pharmaceutical; quercetin is the natural component. Human trials showed measurable reductions in senescent cell burden and biological age.

Senolytics dasatinib and quercetin were reported to reduce biological age by approximately 2.5 years in human subjects in a 2024 analysis of intervention subjects.

Quercetin activates the SIRT6-Nrf2 axis — the master antioxidant defence pathway. A 2025 clinical study confirmed quercetin supplementation activated this axis, sustaining DNA repair capacity and stabilising inflammatory markers during oxidative stress.

Quercetin amplifies fisetin's senolytic potency when combined — the Mayo Clinic screening found the pairing creates stronger and more sustained senolytic effects. Fisetin is the stronger senolytic; quercetin adds senomorphic and Nrf2 activation dimensions fisetin lacks.

Onions, apples, capers, berries, broccoli, and green tea are the richest dietary sources. Capers have the highest quercetin content per gram of any common food.

500-1,000mg/day for up to 12 weeks is well-tolerated in human studies. No clinically significant adverse effects have been reported at standard supplemental doses.

Yes. Quercetin directly inhibits NF-kB transcriptional activity — the primary driver of SASP inflammatory output. Studies show dose-dependent reduction in TNF-alpha, IL-6, and IL-1beta.

By activating Nrf2, quercetin upregulates the body's own antioxidant enzymes, reducing the oxidative stress that pushes healthy cells into the senescent state. This prevention dimension is not present in fisetin, urolithin A, or spermidine at the same mechanistic level.

Clinical studies have used 500-1,000mg/day for up to 12 weeks. Typical supplement doses range from 500mg to 1,000mg daily.

A Phase 2 trial showed D+Q improved bone formation markers in osteoporosis patients — consistent with zombie cell removal from bone marrow, where senescent cells impair osteoblast function.